Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05682989

Efficacy/Safety of Urogynecology Synthetic Mesh Surgery

Conditions: Pelvic Organ Prolapse

Sex: Female
Ages: 30 Years – 100 Years
Enrollment: 150
Sponsor: Mackay Medical College

Location: Taiwan

Summary

This is a retrospective cohort study, aiming at analyzing the efficacy and safety of mesh surgery in pelvic organ prolapse. The synthetic mesh for pelvic organ prolapse include transvaginal mesh or laparotomy, laparoscope, or robotic-assisted laparoscopic sacrocolpopexy with mesh augmentation. The investigators would like to evaluate the efficacy and safety, such as recurrence rates and complication rates for women who underwent urogynecology mesh surgery.

Eligibility Criteria

Inclusion Criteria:Pelvic organ prolapse patients with objective / subjective voiding dysfunctionsUnderwent surgery for symptomatic POP ≥ stage II (POP-Q system)Exclusion Criteria:Patients with a history of pelvic radiation.Patients with a history of vesico-/recto-/urethra-vaginal fistulaPatients unable to be followed up.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05682989). StuddyBuddy aggregates publicly available trial information.